StartupsFinSMEsabout 1 hour ago
AdvanCell Closes US $315M in Series D Funding
1 min read
AdvanCell closed US $315 million in Series D funding. The round supports the company's development of targeted alpha therapies for cancer treatment. The financing marks one of the larger private raises in the radiopharmaceutical sector.
Level
Hype check
Tap to vote and see what everyone thinks.
Summary by ByteBrief
